Robb Knie
CEO and President, Director · Hoth Therapeutics, Inc.
Individual
- 2025
- May 28, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Robb Knie's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robb Knie?
Robb Knie is a corporate insider, tracked as CEO and President, Director of Hoth Therapeutics, Inc. (RKTO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Robb Knie last file a Form 4?
The most recent primary Form 4 on record is dated 28 May 2026, one of 2 filings going back to 2025.
